These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12086968)

  • 21. Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the Atherosclerosis Risk in Communities Study.
    Kao WH; Coresh J; Shuldiner AR; Boerwinkle E; Bray MS; Brancati FL;
    Diabetes; 2003 Jun; 52(6):1568-72. PubMed ID: 12765972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians.
    Muller YL; Bogardus C; Beamer BA; Shuldiner AR; Baier LJ
    Diabetes; 2003 Jul; 52(7):1864-71. PubMed ID: 12829658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fetal and maternal peroxisome proliferator-activated receptor gamma2 Pro12Ala does not influence birth weight.
    Pfab T; Poralla C; Richter CM; Godes M; Slowinski T; Priem F; Halle H; Hocher B
    Obesity (Silver Spring); 2006 Nov; 14(11):1880-5. PubMed ID: 17135601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A possible association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 gene with obesity in native Javanese in Indonesia.
    Danawati CW; Nagata M; Moriyama H; Hara K; Yasuda H; Nakayama M; Kotani R; Yamada K; Sakata M; Kurohara M; Wiyono P; Asdie H; Sakaue M; Taniguchi H; Yokono K
    Diabetes Metab Res Rev; 2005; 21(5):465-9. PubMed ID: 15739197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients.
    Zietz B; Barth N; Spiegel D; Schmitz G; Schölmerich J; Schäffler A
    Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):60-6. PubMed ID: 11928067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism is associated with reduced risk for ischemic stroke with type 2 diabetes.
    Lee BC; Lee HJ; Chung JH
    Neurosci Lett; 2006 Dec; 410(2):141-5. PubMed ID: 17084528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes.
    Hara K; Okada T; Tobe K; Yasuda K; Mori Y; Kadowaki H; Hagura R; Akanuma Y; Kimura S; Ito C; Kadowaki T
    Biochem Biophys Res Commun; 2000 Apr; 271(1):212-6. PubMed ID: 10777704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Influence of polymorphism pro12Ala of PPARgamma gene on endothelium destruction in patients with diabetes mellitus t. 2].
    Gacka M; Dobosz T; Szymaniec S; Bednarska-Chabowska D; Adamiec R
    Pol Arch Med Wewn; 2005 Nov; 114(5):1055-65. PubMed ID: 16789503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the Peroxisome Proliferator Activated Receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus.
    Meirhaeghe A; Fajas L; Helbecque N; Cottel D; Auwerx J; Deeb SS; Amouyel P
    Int J Obes Relat Metab Disord; 2000 Feb; 24(2):195-9. PubMed ID: 10702770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association of Pro12Ala polymorphism in PPARgamma2 with lower carotid artery IMT in Japanese.
    Iwata E; Yamamoto I; Motomura T; Tsubakimori S; Nohnen S; Ohmoto M; Igarashi T; Azuma J
    Diabetes Res Clin Pract; 2003 Oct; 62(1):55-9. PubMed ID: 14581158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2 gene on metabolic syndrome risk: a meta-analysis.
    Zhang R; Wang J; Yang R; Sun J; Chen R; Luo H; Liu D; Cai D
    Gene; 2014 Feb; 535(1):79-87. PubMed ID: 24012868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between peroxisome proliferator-activated receptor-gamma 2 gene polymorphisms and size at birth on blood pressure and the use of antihypertensive medication.
    Ylihärsilä H; Eriksson JG; Forsén T; Laakso M; Uusitupa M; Osmond C; Barker DJ
    J Hypertens; 2004 Jul; 22(7):1283-7. PubMed ID: 15201543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism.
    Ylönen SK; Salminen I; Lyssenko V; Virtanen SM; Groop L; Aro A; Saloranta C;
    Eur J Clin Nutr; 2008 Dec; 62(12):1432-9. PubMed ID: 17700648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does peroxisome proliferator-activated receptor gamma genotype (Pro12ala) modify the association of physical activity and dietary fat with fasting insulin level?
    Franks PW; Luan J; Browne PO; Harding AH; O'Rahilly S; Chatterjee VK; Wareham NJ
    Metabolism; 2004 Jan; 53(1):11-6. PubMed ID: 14681835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of the PPAR-gamma2 Pro12Ala and ACE I/D polymorphisms on insulin sensitivity and training effects in healthy offspring of type 2 diabetic subjects.
    Østergård T; Ek J; Hamid Y; Saltin B; Pedersen OB; Hansen T; Schmitz O
    Horm Metab Res; 2005 Feb; 37(2):99-105. PubMed ID: 15778927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The proline 12 alanine substitution in the peroxisome proliferator--activated receptor-gamma2 gene is associated with lower lipoprotein lipase activity in vivo.
    Schneider J; Kreuzer J; Hamann A; Nawroth PP; Dugi KA
    Diabetes; 2002 Mar; 51(3):867-70. PubMed ID: 11872694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
    Andrulionyte L; Peltola P; Chiasson JL; Laakso M;
    Diabetes; 2006 Jul; 55(7):2148-52. PubMed ID: 16804087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population.
    Meshkani R; Taghikhani M; Larijani B; Bahrami Y; Khatami S; Khoshbin E; Ghaemi A; Sadeghi S; Mirkhani F; Molapour A; Adeli K
    Clin Chem Lab Med; 2007; 45(4):477-82. PubMed ID: 17439324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes.
    Clement K; Hercberg S; Passinge B; Galan P; Varroud-Vial M; Shuldiner AR; Beamer BA; Charpentier G; Guy-Grand B; Froguel P; Vaisse C
    Int J Obes Relat Metab Disord; 2000 Mar; 24(3):391-3. PubMed ID: 10757637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Pro12Ala polymorphism in the PPAR-γ2 gene is not associated with an increased risk of NAFLD in Iranian patients with type 2 diabetes mellitus.
    Saremi L; Lotfipanah S; Mohammadi M; Hosseinzadeh H; Fathi-Kazerooni M; Johari B; Saltanatpour Z
    Cell Mol Biol Lett; 2019; 24():12. PubMed ID: 30923554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.